Release Date: February 10, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Femcare sales have been weak, and you've mentioned consolidating the brand portfolio. Can you explain why the business is still struggling and if the spring resets will help? A: The category is healthy overall, driven by pads, where we're currently challenged. We've been transitioning consumers from Stay Free to Carefree pads, which is taking longer than expected. However, we're making progress, and results should improve sequentially throughout the year due to easier comparisons and ongoing consumer conversion efforts.
Q: Can you provide context on the businesses experiencing atypically negative performance and when they might improve? A: Improvement is expected primarily in the second half of the year. Supply chain issues from last year, like the fire in our manufacturing plant, are being resolved. Wet Ones is already back online, and other areas like EDGE and Cremo will start to improve as we lap those periods in the summer.
Q: FX is a bigger hit this year. What are your plans to offset this, and are you considering pricing changes? A: The FX impact is heavier than anticipated, but we're maintaining our profit guidance within the original ranges. While we've executed planned pricing for 2025, we are focusing on revenue management, optimizing trade terms, and managing mix. We are not planning to cut brand investments to offset FX impacts.
Q: How do you view your position in the sun care market as we head into the peak season? A: We feel well-positioned for the sun season with strong distribution and innovation. We're optimistic about weather patterns and have good retailer support. Internationally, we've seen strong performance, winning market share in Australia and Mexico. Our innovation pipeline, including a complete mineral restage in the US, is robust.
Q: What are your updated thoughts on capital allocation and potential M&A? A: We've been focusing on deleveraging and share buybacks, but M&A remains important for growth. We're active in the market, though valuations are challenging. We wouldn't shy away from acquisitions that are meaningful to our growth. Share repurchase is also a good use of capital given our current valuation.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。